However, we found that the activation marker CD69 was expressed by CD4+ T cells in AF mothers at a significantly higher rate than that in NAF mothers at 26–28 weeks of gestation (before antiviral intervention) and 15–18 weeks after birth (p = 0.04, p = 0.04) (Fig. 2D). This evidence concerns the gene CD4 and atrial fibrillation.